Editors' ChoiceCancer Predictive biomarkers for HDAC inhibitor efficacy Leslie K. FerrarelliScience Signaling, AAAS, Washington, DC 20005, USA See allHide authors and affiliations Science Signaling 05 Jul 2016:Vol. 9, Issue 435, pp. ec155DOI: 10.1126/scisignal.aah4647 Leslie K. Ferrarelli , AAAS, Washington, DC 20005, USAFind this author on Google Scholar Find this author on PubMed Search for this author on this site Article Info & Metrics eLetters Article Information vol. 9 no. 435 ec155 DOI: https://doi.org/10.1126/scisignal.aah4647 Published By: Science Signaling Print ISSN: 1945-0877 Online ISSN: 1937-9145 History: . Copyright & Usage: Copyright © 2016, American Association for the Advancement of Science Author Information Leslie K. FerrarelliScience Signaling, AAAS, Washington, DC 20005, USA Altmetric Article usage Article lifetimeLast 6 monthsThis monthArticle usage: June 2016 to January 2021 AbstractFullPdf Jun 2016400 Jul 2016275200 Aug 201610600 Sep 20167000 Oct 20163900 Nov 20164700 Dec 20162300 Jan 20171400 Feb 20173400 Mar 20171700 Apr 20172800 May 20173700 Jun 20172100 Jul 20171600 Aug 20173900 Sep 20172600 Oct 20171600 Nov 20173500 Dec 20172500 Jan 20183200 Feb 20183700 Mar 20183400 Apr 20182300 May 20181600 Jun 20182600 Jul 20181800 Aug 20181700 Sep 20181600 Oct 20182300 Nov 20182700 Dec 20182200 Jan 20192500 Feb 20191700 Mar 20192300 Apr 20191100 May 20191600 Jun 20191300 Jul 20191300 Aug 2019900 Sep 20191501 Oct 20191800 Nov 20191400 Dec 20191100 Jan 20201600 Feb 20201101 Mar 20201700 Apr 20201801 May 2020900 Jun 20202100 Jul 20202500 Aug 20202100 Sep 2020800 Oct 20201900 Nov 20201400 Dec 20202300 Jan 20211400 View Abstract
Predictive biomarkers for HDAC inhibitor efficacy By Leslie K. Ferrarelli Science Signaling05 Jul 2016 : ec155 High abundance of the E3 ligase FBW7 may predict therapeutic efficacy of HDAC inhibitors in ΔNp63-positive tumors.
Predictive biomarkers for HDAC inhibitor efficacy By Leslie K. Ferrarelli Science Signaling05 Jul 2016 : ec155 High abundance of the E3 ligase FBW7 may predict therapeutic efficacy of HDAC inhibitors in ΔNp63-positive tumors.